18-Sept-2026 18:56:34
SHILPAMEDGeneral news
SHILPA MEDICARE : USFDA INSPECTION AT UNIT VII CONCLUDED
• USFDA conducted a Surveillance Inspection at Unit VII, Analytical Services Division, Hyderabad from 16 September 2026 to 18 September 2026. • The inspection concluded with one procedural observation, neither a repeat nor related to data integrity. • The company will address the observation and respond within the stipulated timeline. • Details of the inspection are enclosed as Annexure A. • The information is also available on the company's website www.vbshilpa.com Impact: Neutral (Routine regulatory inspection with a procedural observation, no data integrity concerns raised)
Shilpa Medicare Ltd
Open attachment